<VariationArchive RecordType="classified" VariationID="565298" VariationName="NM_001604.5(PAX6):c.(10+1_11-1)_(1311_?)del" VariationType="Deletion" Accession="VCV000565298" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-09-03" DateCreated="2018-09-10" MostRecentSubmission="2018-09-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="551625" VariationID="565298">
      <GeneList>
        <Gene Symbol="ELP4" FullName="elongator acetyltransferase complex subunit 4" GeneID="26610" HGNC_ID="HGNC:1171" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11p13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="31509767" stop="31790324" display_start="31509767" display_stop="31790324" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="31531296" stop="31805328" display_start="31531296" display_stop="31805328" Strand="+" />
          </Location>
          <OMIM>606985</OMIM>
        </Gene>
        <Gene Symbol="LOC106007485" FullName="enhancer region in intron 7 of PAX6" GeneID="106007485" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11p13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="31794904" stop="31799706" display_start="31794904" display_stop="31799706" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC106007493" FullName="regulatory region in intron 4 of PAX6" GeneID="106007493" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11p13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="31804115" stop="31804358" display_start="31804115" display_stop="31804358" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="PAX6" FullName="paired box 6" GeneID="5080" HGNC_ID="HGNC:8620" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11p13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="31789026" stop="31817961" display_start="31789026" display_stop="31817961" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="31806339" stop="31839508" display_start="31806339" display_stop="31839508" Strand="-" />
          </Location>
          <OMIM>607108</OMIM>
          <Haploinsufficiency last_evaluated="2015-11-05" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PAX6">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2015-11-05" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PAX6">Little evidence for dosage pathogenicity</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001604.5(PAX6):c.(10+1_11-1)_(1311_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" innerStart="31789934" innerStop="31802835" outerStop="31806401" display_start="31789934" display_stop="31806401" variantLength="12902" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" innerStart="31811482" innerStop="31824383" outerStop="31827949" display_start="31811482" display_stop="31827949" variantLength="12902" />
      </Location>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008679.1" sequenceAccession="NG_008679" sequenceVersion="1" change="g.(16561_20127)_(33028_?)del">
            <Expression>NG_008679.1:g.(16561_20127)_(33028_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_720" sequenceAccession="LRG_720" change="g.(16561_20127)_(33028_?)del">
            <Expression>LRG_720:g.(16561_20127)_(33028_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.(?_31789934)_(31802835_31806401)del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.(?_31789934)_(31802835_31806401)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.(?_31811482)_(31824383_31827949)del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.(?_31811482)_(31824383_31827949)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001604.5(PAX6):c.(10+1_11-1)_(1311_?)del AND Congenital aniridia" Accession="RCV000678591" Version="2">
        <ClassifiedConditionList TraitSetID="17309">
          <ClassifiedCondition DB="MedGen" ID="C0003076">Congenital aniridia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2016-09-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2016-09-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-09-10" MostRecentSubmission="2018-09-10">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="17309" Type="Finding" ContributesToAggregateClassification="true">
            <Trait ID="36295" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Aniridia</ElementValue>
                <XRef ID="HP:0000526" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0019172" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Congenital aniridia</ElementValue>
                <XRef ID="Congenital+aniridia/8046" DB="Genetic Alliance" />
                <XRef ID="69278003" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AN</ElementValue>
                <XRef Type="MIM" ID="106210" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">PAX6-related aniridia occurs either as an isolated ocular abnormality or as part of the Wilms tumor-aniridia-genital anomalies-retardation (WAGR) syndrome. Aniridia is a pan ocular disorder affecting the cornea, iris, intraocular pressure (resulting in glaucoma), lens (cataract and lens subluxation), fovea (foveal hypoplasia), and optic nerve (optic nerve coloboma and hypoplasia). Individuals with aniridia characteristically show nystagmus and impaired visual acuity (usually 20/100 - 20/200); however, milder forms of aniridia with subtle iris architecture changes, good vision, and normal foveal structure do occur. Other ocular involvement may include strabismus and occasionally microphthalmia. Although the severity of aniridia can vary between and within families, little variability is usually observed in the two eyes of an affected individual. WAGR syndrome. The risk for Wilms tumor is 42.5%-77%; of those who develop Wilms tumor, 90% do so by age four years and 98% by age seven years. Genital anomalies in males can include cryptorchidism and hypospadias (sometimes resulting in ambiguous genitalia), urethral strictures, ureteric abnormalities, and gonadoblastoma. While females typically have normal external genitalia, they may have uterine abnormalities and streak ovaries. Intellectual disability (defined as IQ &lt;74) is observed in 70%; behavioral abnormalities include attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, anxiety, depression, and obsessive-compulsive disorder. Other individuals with WAGR syndrome can have normal intellect without behavioral problems.</Attribute>
                <XRef ID="NBK1360" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301534</ID>
                <ID Source="BookShelf">NBK1360</ID>
              </Citation>
              <XRef ID="C0003076" DB="MedGen" />
              <XRef ID="MONDO:0019172" DB="MONDO" />
              <XRef Type="primary" ID="HP:0000526" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1569349" SubmissionDate="2016-09-14" DateLastUpdated="2018-09-10" DateCreated="2018-09-10">
        <ClinVarSubmissionID localKey="NM_001604.5:c.(10+1_11-1)_(1311_?)del|Aniridia" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000804673" DateUpdated="2018-09-10" DateCreated="2018-09-10" Type="SCV" Version="2" SubmitterName="Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+" OrgID="505925" OrganizationCategory="laboratory" OrgAbbreviation="Radboudumc_MUMC+" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-09-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PAX6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NG_008679.1:g.(16561_20127)_(33028_?)del</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001604.5:c.(10+1_11-1)_(1311_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Aniridia</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyDescription>Variants as described in Haer-Wigman et al. 2016</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>haerwigman2016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1569349" TraitType="Disease" MappingType="Name" MappingValue="Aniridia" MappingRef="Preferred">
        <MedGen CUI="C0003076" Name="Congenital aniridia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

